This is the company profile provided by Baidu.
Chongqing Xi 'an Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise integrating R&D, production, sales, planting of Chinese herbal medicines and processing of Chinese herbal pieces, focusing on the production of Chinese patent medicines. It is a key high-tech enterprise of the national torch plan, a key leading enterprise of national agricultural industrialization and a leading enterprise of national poverty alleviation. It has been rated as AAA credit enterprise by tax authorities and Agricultural Bank of China for many years. The company was established in 1997. In 2002, it completed the asset reorganization of Chongqing Chinese Medicine Factory with a registered capital of 40 million yuan and total assets of 8 10/00000 yuan. The production and R&D area covers an area of more than 200 mu with a building area of 20,000 ㎡. There are about 670 employees, including 3 doctors and postdocs, 2 master students/kloc-0, and 38 middle and senior titles. College degree or above accounts for more than 73% of the total employees, and technicians account for 4 1% of the total employees. Product introduction ● 306 drug production approvals ● 13 varieties obtained the national certificate of protection of traditional Chinese medicine; 20 national exclusive varieties, 17 varieties obtained the national invention patent certificate, 2 national "high quality and good price" Chinese patent medicines, and 69 varieties were listed in the national basic medical insurance drug list; Thirty-five varieties were listed in the national list of essential drugs. Musk Haima Zhuifeng Ointment is a national key new product, and Zhuanggu Musk Zhitong Ointment, Compound Zaoren Capsule, Compound Mylabris Capsule, Dabaidu Capsule and Xinkeshu Capsule are well-known brands in China. And has "Xi 'an" and "Guoguang" two famous trademarks. ● Capsule, granule, tablet, pill, rubber paste, etc. 18 has passed the national GMP certification.
Edit this technical research
The company has two research institutes, Chongqing Cisco Pharmaceutical Research Institute and Chongqing Kerun Biomedical R&D Co., Ltd., to undertake scientific research and development. Up to now, the company has successfully developed 2 new biological drugs, 7 new drugs 1 drug, and 47 new Chinese medicine drugs. He has undertaken nearly 20 national, provincial and municipal scientific research projects. Up to now, it has formed a solid industrial chain pattern of raw material base (GAP planting), deep processing base (Chinese herbal pieces and extracts), production base (including new drug research and development center) and sales (huge market network), which has laid a solid foundation for developing into a large-scale Chinese medicine pharmaceutical enterprise group.
Editing this paragraph was honored.
From June 2006 to October 2006 10, the company's product "Musk Haima Zhuifeng Ointment" was rated as "National Key New Product" by the Ministry of Science and Technology, the Ministry of Commerce, the General Administration of Quality Supervision, Inspection and Quarantine and the State Environmental Protection Administration. In 2005, it was recognized by the Ministry of Science and Technology as the key high-tech enterprise of the National Torch Program, in 2005 by the the State Council Office for Poverty Alleviation and Development, and in June 2004, it was recognized by the Ministry of Agriculture, the National Development and Reform Commission, the Ministry of Finance, the Ministry of Commerce, the People's Bank of China, the State Taxation Administration of The People's Republic of China Securities Regulatory Commission of People's Republic of China (PRC) and China, and the All-China Federation of Supply and Marketing Cooperatives.